GenBody America is standing by the accuracy of its COVID-19 rapid antigen test, after being contacted by the Utah Department of Health regarding concerns about the test's performance.
On February 6, the Utah Department of Health said it had stopped using GenBody rapid antigen tests following concerns about data raised by department epidemiologists. The department said that among people who tested positive on polymerase chain reaction (PCR) tests, more than half of them tested negative with the GenBody test. The department said this occurred even in individuals who reported COVID-like symptoms.
But the company reported it had investigated the state's concerns. "The figures cited by the State of Utah conflict with our experience in the remainder of the country and in our clinical trials," CEO David Yoo said in a statement.
GenBody America "looks forward to working with the State of Utah to better understand the process the State created and implemented related to the administration of our test," the company said.
